Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus

Gynecologic Oncology

Volumn 123, Issue 1, 2011, Pages 138-146

  Rein, Daniel T ^a   Volkmer, Anne ^a   Beyer, Ines M ^a,d   Curiel, David T ^b   Janni, Wolfgang ^a   Dragoi, Anca ^a   Hess, Alexandra P ^a   Maass, Nicolai ^c   Baldus, Stephan E ^a   Bauerschmitz, Gerd ^a   Breidenbach, Martina ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoresistant; Gene therapy; Mdr 1; Ovarian cancer

Indexed keywords

CONDITIONALLY REPLICATING ADENOVIRUS; MULTIDRUG RESISTANCE PROTEIN 1; ONCOLYTIC ADENOVIRUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL KILLING; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; FEMALE; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER TOXICITY; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VIRAL GENE THERAPY; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; LIVER; MICE; MICE, INBRED C57BL; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; PROMOTER REGIONS, GENETIC; VIRUS REPLICATION;

EID: 80052591736     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.06.007     Document Type: Article

References (45)

1. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66 (Pubitemid 46148091)
2. M. Raki, D.T. Rein, A. Kanerva, and A. Hemminki Gene transfer approaches for gynecological diseases Mol Ther 14 2006 154 163 (Pubitemid 43942349)
3. D.T. Rein, M. Breidenbach, and D.T. Curiel Current developments in adenovirus-based cancer gene therapy Future Oncol 2 2006 137 143
4. G.J. Bauerschmitz, S.D. Barker, and A. Hemminki Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review) Int J Oncol 21 2002 1161 1174
5. A. Kanerva, and A. Hemminki Adenoviruses for treatment of cancer Ann Med 37 2005 33 43 (Pubitemid 40342423)
6. R. Alemany, and D.T. Curiel CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors Gene Ther 8 2001 1347 1353 (Pubitemid 32834304)
7. J.R. Bischoff, D.H. Kirn, A. Williams, C. Heise, S. Horn, and M. Muna An adenovirus mutant that replicates selectively in p53-deficient human tumor cells Science 274 1996 373 376 (Pubitemid 26353341)
8. J. Fueyo, C. Gomez-Manzano, R. Alemany, P.S. Lee, T.J. McDonnell, and P. Mitlianga A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo Oncogene 19 2000 2 12 (Pubitemid 30066345)
9. M. Yamamoto, J. Davydova, M. Wang, G.P. Siegal, V. Krasnykh, and S.M. Vickers Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer Gastroenterology 125 2003 1203 1218 (Pubitemid 37193465)
10. M.R. Raspollini, G. Amunni, A. Villanucci, G. Baroni, V. Boddi, and G.L. Taddei Prognostic value of P-glycoprotein and proliferative index in advanced low grade serous ovarian carcinomas J Chemother 15 2003 380 386 (Pubitemid 36904324)
11. R. Agarwal, and S.B. Kaye Ovarian cancer: strategies for overcoming resistance to chemotherapy Nat Rev Cancer 3 2003 502 516 (Pubitemid 37328838)
12. J.P. Annereau, G. Szakacs, C.J. Tucker, A. Arciello, C. Cardarelli, and J. Collins Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance Mol Pharmacol 66 2004 1397 1405 (Pubitemid 39564766)
13. S. Lu, X. Wang, L. Xiao, L. Cai, Y. Zhang, and H. Wang Gene therapy for ovarian cancer using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene directed by MDR1 promoter Cancer Biol Ther 6 2007 397 404 (Pubitemid 47328308)
14. J.T. Douglas, M. Kim, L.A. Sumerel, D.E. Carey, and D.T. Curiel Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors Cancer Res 61 2001 813 817 (Pubitemid 32174383)
15. I. Dmitriev, V. Krasnykh, C.R. Miller, M. Wang, E. Kashentseva, and G. Mikheeva An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism J Virol 72 1998 9706 9713 (Pubitemid 28520834)
16. T.J. Vanderkwaak, M. Wang, J. Gomez-Navarro, C. Rancourt, I. Dmitriev, and V. Krasnykh An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches Gynecol Oncol 74 1999 227 234 (Pubitemid 29377217)
17. A.G. Zeimet, E. Muller-Holzner, A. Schuler, G. Hartung, J. Berger, and M. Hermann Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas Gene Ther 9 2002 1093 1100
18. T. Okegawa, R.C. Pong, Y. Li, J.M. Bergelson, A.I. Sagalowsky, and J.T. Hsieh The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure Cancer Res 61 2001 6592 6600 (Pubitemid 32783269)
19. M. Breidenbach, D.T. Rein, T. Schondorf, K.N. Khan, I. Herrmann, and T. Schmidt A new targeting approach for breast cancer gene therapy using the heparanase promoter Cancer Lett 240 2006 114 122 (Pubitemid 44055993)
20. D.T. Rein, M. Breidenbach, H. Wu, T. Han, Y.S. Haviv, and M. Wang Gene transfer to cervical cancer with fiber-modified adenoviruses Int J Cancer 111 2004 698 704 (Pubitemid 39062891)
21. T. Ranki, A. Kanerva, A. Ristimaki, T. Hakkarainen, M. Sarkioja, and L. Kangasniemi A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer Gene Ther 14 2007 58 67 (Pubitemid 44942866)
22. A. Kanerva, M. Wang, G.J. Bauerschmitz, J.T. Lam, R.A. Desmond, and S.M. Bhoola Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses Mol Ther 5 2002 695 704 (Pubitemid 34619062)
23. A. Kanerva, G.V. Mikheeva, V. Krasnykh, C.J. Coolidge, J.T. Lam, and P.J. Mahasreshti Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells Clin Cancer Res 8 2002 275 280 (Pubitemid 34101488)
24. J.T. Lam, G.J. Bauerschmitz, A. Kanerva, S.D. Barker, J.M. Straughn, and M. Wang Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids Cancer Gene Ther 10 2003 377 387 (Pubitemid 36528781)
25. V. Speirs, A.R. Green, D.S. Walton, M.J. Kerin, J.N. Fox, and P.J. Carleton Short-term primary culture of epithelial cells derived from human breast tumours Br J Cancer 78 1998 1421 1429 (Pubitemid 28517537)
26. T.C. He, S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein A simplified system for generating recombinant adenoviruses Proc Natl Acad Sci U S A 95 1998 2509 2514 (Pubitemid 28145972)
27. A. Kanerva, K.R. Zinn, T.R. Chaudhuri, J.T. Lam, K. Suzuki, and T.G. Uil Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus Mol Ther 8 2003 449 458 (Pubitemid 37167933)
28. J. Davydova, L.P. Le, T. Gavrikova, M. Wang, V. Krasnykh, and M. Yamamoto Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment Cancer Res 64 2004 4319 4327 (Pubitemid 38802439)
29. A. Hemminki, N. Belousova, K.R. Zinn, B. Liu, M. Wang, and T.R. Chaudhuri An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression Mol Ther 4 2001 223 231 (Pubitemid 32851286)
30. J.L. Jakubczak, P. Ryan, M. Gorziglia, L. Clarke, L.K. Hawkins, and C. Hay An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy Cancer Res 63 2003 1490 1499 (Pubitemid 36373634)
31. S.B. Kaye Reversal of drug resistance in ovarian cancer: where do we go from here? J Clin Oncol 26 2008 2616 2618
32. P.P. Szotek, R. Pieretti-Vanmarcke, P.T. Masiakos, D.M. Dinulescu, D. Connolly, and R. Foster Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness Proc Natl Acad Sci U S A 103 2006 11154 11159 (Pubitemid 44156488)
33. S.A. Bapat, A.M. Mali, C.B. Koppikar, and N.K. Kurrey Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer Cancer Res 65 2005 3025 3029 (Pubitemid 40524578)
34. A.M. Puumalainen, M. Vapalahti, R.S. Agrawal, M. Kossila, J. Laukkanen, and P. Lehtolainen Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses Hum Gene Ther 9 1998 1769 1774 (Pubitemid 28418747)
35. M. Raki, M. Sarkioja, R.A. Desmond, D.T. Chen, R. Butzow, and A. Hemminki Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer Gynecol Oncol 108 2008 166 172 (Pubitemid 350299441)
36. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan, and M.C. Willingham Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc Natl Acad Sci U S A 84 1987 7735 7738
37. D.T. Rein, M. Breidenbach, T.O. Kirby, T. Han, G.P. Siegal, and G.J. Bauerschmitz A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer Clin Cancer Res 11 2005 1327 1335 (Pubitemid 40175787)
38. G.J. Bauerschmitz, A. Kanerva, M. Wang, I. Herrmann, D.R. Shaw, and T.V. Strong Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer Int J Cancer 111 2004 303 309 (Pubitemid 38924711)
39. Y. Tsuruta, M. Mandai, I. Konishi, H. Kuroda, T. Kusakari, and Y. Yura Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines Eur J Cancer 37 2001 531 541 (Pubitemid 32232119)
40. A. Hasenburg, D.C. Fischer, X.W. Tong, A. Rojas-Martinez, R.H. Kaufman, and I. Ramzy Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5 J Soc Gynecol Investig 9 2002 174 180 (Pubitemid 34497147)
41. S. Dauchy, F. Miller, P.O. Couraud, R.J. Weaver, B. Weksler, and I.A. Romero Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells Biochem Pharmacol 77 2009 897 909
42. K.V. Chin, and B. Liu Regulation of the multidrug resistance (MDR1) gene expression In Vivo 8 1994 835 841
43. B.A. Jessen, J.S. Mullins, A. De Peyster, and G.J. Stevens Assessment of hepatocytes and liver slices as in vitro test systems to predict in vivo gene expression Toxicol Sci 75 2003 208 222 (Pubitemid 37098753)
44. S.A. Wrighton, B.J. Ring, and M. VandenBranden The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies Toxicol Pathol 23 1995 199 208
45. P.A. Vasey, L.N. Shulman, S. Campos, J. Davis, M. Gore, and S. Johnston Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer J Clin Oncol 20 2002 1562 1569 (Pubitemid 34260536)